Pharmaceuticals Industry Distribution Agreements

Third Amendment to Exclusive Distribution Agreement dated December 22, 2022, by and between Revance Therapeutics, Inc. and Teoxane SA (Revance Therapeutics, Inc., Filed With SEC on February 28, 2023)

Structured Monitoring Products, Inc. Distribution Agreement dated January 13, 2023 by and between Zomedica Inc. and Structured Monitoring Products, Inc (Zomedica Pharmaceuticals Corp., Filed With SEC on January 20, 2023)

Amendment No. 6, dated as of August 24, 2022, to Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts... (Jazz Pharmaceuticals plc, Filed With SEC on November 9, 2022)

Second Amendment to Exclusive Distribution Agreement, dated November 18, 2020, by and between Revance Therapeutics, Inc. and Teoxane SA (Revance Therapeutics, Inc., Filed With SEC on November 8, 2022)

Distribution Services Agreement, dated August 4, 2017, between Corcept Therapeutics Incorporated and Optime Care, Inc (Corcept Therapeutics Incorporated, Filed With SEC on November 3, 2022)

Task Order Number One to Distribution Services Agreement, dated August 4, 2017, between Corcept Therapeutics Incorporated and Optime Care, Inc (Corcept Therapeutics Incorporated, Filed With SEC on November 3, 2022)

Amendment to Distribution Services Agreement by and between Optime Care, Inc. and Corcept Therapeutics Incorporated, made and entered into as of August 1, 2022 (Corcept Therapeutics Incorporated, Filed With SEC on November 3, 2022)

Amendment No. 2 to Distribution Services Agreement by and between Optime Care, Inc. and Corcept Therapeutics Incorporated, made and entered into as of September 16, 2022 (Corcept Therapeutics Incorporated, Filed With SEC on November 3, 2022)

Amendment No. 5, dated as of June 24, 2022, to Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts... (Jazz Pharmaceuticals plc, Filed With SEC on August 3, 2022)

Amendment No. 4, dated as of April 18, 2022 to Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts... (Jazz Pharmaceuticals plc, Filed With SEC on May 4, 2022)

PrimeX Distribution Agreement (Canbiola, Inc., Filed With SEC on April 15, 2022)

Distribution Agreement (MICROCHANNEL TECHNOLOGIES CORP, Filed With SEC on November 12, 2021)

Distribution Agreement Between Respirent Pharmaceuticals Co. Ltd. and Lannett Company, Inc (Lannett Company, Inc., Filed With SEC on August 26, 2021)

Amendment No. 1 to Distribution Agreement Between Respirent Pharmaceuticals Co. Ltd. and Lannett Company, Inc (Lannett Company, Inc., Filed With SEC on August 26, 2021)

Amendment No. 1, dated as of July 4, 2021 to Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts Specialty... (Jazz Pharmaceuticals plc, Filed With SEC on August 3, 2021)

Amendment No. 2, dated as of July 19, 2021 to Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts Specialty... (Jazz Pharmaceuticals plc, Filed With SEC on August 3, 2021)

Co-Development and Distribution Agreement, by and between Leading BioSciences, Inc. and Newsoara Biopharma Co., Ltd. (as successor-in-interest to Biolead Medical Technology... (Neuralstem, Inc., Filed With SEC on December 23, 2020)

Licensing and Distribution Agreement between Sonoma Pharmaceuticals, Inc. and Gabriel Science, LLC, effective December 14, 2020 (Sonoma Pharmaceuticals, Inc., Filed With SEC on December 17, 2020)

Exclusive Licensing and Distribution Agreement between Sonoma Pharmaceuticals, Inc. and Crown Laboratories, Inc., effective December 4, 2020 (Sonoma Pharmaceuticals, Inc., Filed With SEC on December 10, 2020)

First Amendment to Exclusive Distribution Agreement (Revance Therapeutics, Inc., Filed With SEC on November 9, 2020)

Distribution Agreement between the Registrant and Biomet 3i LLC d/b/a Zimmer Biomet Dental, dated July 17, 2020 (ACELRX PHARMACEUTICALS INC, Filed With SEC on November 5, 2020)

Distribution and Commercialization Agreement between the Company and USWM, LLC (Adamis Pharmaceuticals Corp, Filed With SEC on August 17, 2020)

First Amendment to Intermediary Distribution Agreement between the Company and Chongqing Pioneer Pharma Holdings Limited, dated June 29, 2020 (NovaBay Pharmaceuticals, Inc., Filed With SEC on August 6, 2020)

Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts Specialty Distribution Services, Inc (Jazz Pharmaceuticals plc, Filed With SEC on August 4, 2020)

Distribution Agreement between the Company and Sai Krishna LLC, dated April 30, 2019 filed on Current Report 8-K on May 3, 2019 (TAURIGA SCIENCES, INC., Filed With SEC on June 29, 2020)

International Distribution Agreement, dated April 16, 2020 (NovaBay Pharmaceuticals, Inc., Filed With SEC on April 20, 2020)

Intermediary Distribution Agreement, dated April 16, 2020 (NovaBay Pharmaceuticals, Inc., Filed With SEC on April 20, 2020)

Form of Distribution Agreement dated February 26, 2020 by and among cbdMD, Inc., CBD Holdings, LLC and the members of CBD Holdings, LLC (Level Brands, Inc., Filed With SEC on February 28, 2020)

Exclusive Distribution Agreement, dated January 10, 2020, by and between Revance Therapeutics, Inc. and Teoxane SA (Revance Therapeutics, Inc., Filed With SEC on February 26, 2020)

Distribution Agreement (COSMO VENTURES INC, Filed With SEC on October 11, 2019)

Distribution Agreement between the Company and Windmill Health Products, LLC, dated June 28, 2019 (TAURIGA SCIENCES, INC., Filed With SEC on July 5, 2019)

Amendment No. 1 to Pharmacy Master Services Agreement, effective as of June 30, 2019, by and between Jazz Pharmaceuticals, Inc. and Express Scripts Specialty Distribution... (Jazz Pharmaceuticals plc, Filed With SEC on May 7, 2019)

Distribution Agreement between the Company and Sai Krishna LLC, dated April 30, 2019 (TAURIGA SCIENCES, INC., Filed With SEC on May 3, 2019)

Distribution Agreement between the Company and IRM Management Corporation, dated April 8, 2019 (TAURIGA SCIENCES, INC., Filed With SEC on April 15, 2019)

Distribution Agreement between the Company and E&M Ice Cream Co., dated April 1, 2019 (TAURIGA SCIENCES, INC., Filed With SEC on April 15, 2019)

Distribution Agreement Rights Agreement with RCS International Investments Corp (Profile Solutions, Inc., Filed With SEC on March 5, 2019)

Distribution Agreement with Hemp Premier, Inc (Profile Solutions, Inc., Filed With SEC on March 5, 2019)

Distribution Agreement Rights Agreement with FNS Brands, LLC (Profile Solutions, Inc., Filed With SEC on March 5, 2019)

Distribution Agreement with IT Distribution, LLC (Profile Solutions, Inc., Filed With SEC on March 5, 2019)

Distribution Agreement, dated January 4, 2019, by and between Alder BioPharmaceuticals, Inc. and J.P. Morgan Securities LLC (ALDER BIOPHARMACEUTICALS INC, Filed With SEC on January 4, 2019)

Distribution Agreements in the Pharmaceuticals Industry